Compare RCI & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCI | MEDP |
|---|---|---|
| Founded | 1960 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1B | 15.4B |
| IPO Year | 2002 | 2016 |
| Metric | RCI | MEDP |
|---|---|---|
| Price | $36.59 | $614.06 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 12 |
| Target Price | $44.00 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 925.2K | 251.6K |
| Earning Date | 04-22-2026 | 04-22-2026 |
| Dividend Yield | ★ 4.01% | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 8.53 |
| Revenue | N/A | N/A |
| Revenue This Year | $6.78 | $13.19 |
| Revenue Next Year | $1.45 | $7.75 |
| P/E Ratio | ★ $4.12 | $72.69 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.38 | $373.00 |
| 52 Week High | $41.14 | $677.90 |
| Indicator | RCI | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 61.14 | 61.79 |
| Support Level | $35.64 | $567.90 |
| Resistance Level | $38.90 | $627.59 |
| Average True Range (ATR) | 0.63 | 16.37 |
| MACD | 0.12 | 0.03 |
| Stochastic Oscillator | 86.58 | 69.85 |
Rogers Communications is the largest wireless service provider in Canada with more than 11 million subscribers, equating to one-third of the total Canadian market. Rogers' wireless business accounts for more than half of total revenue and has been growing at a higher rate than other segments. The cable segment, which provides about 38% of total revenue after acquiring Shaw, offers home internet, television, and landline phone service to consumers and businesses. Remaining sales come from Rogers' media unit, which owns and operates various television and radio stations and major Toronto sports franchises, including the Blue Jays, Maple Leafs, Raptors, Toronto FC, and Argonauts.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.